Picture of Bioservo Technologies AB logo

BIOS — Bioservo Technologies AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bioservo Technologies Q4 EBITDA Loss Widens To SEK 15.5 Mln

Feb 22 (Reuters) - Bioservo Technologies AB  BIOSE.ST :
    * BIOSERVO TECHNOLOGIES AB YEAR-END REPORT 2022
    * Q4 NET SALES OF SEK 1.3 M (2.3)
    * Q4 EBITDA OF SEK -15.5 M (-7.5)

Source text for Eikon:  ID:nWkr8K5PNF 
Further company coverage:  BIOSE.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Bioservo Technologies AB

See all news